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ABSTRACT
PvuRts1I is a modification-dependent restriction
endonuclease that recognizes 5-hydroxyme
thylcytosine (5hmC) as well as 5-glucosylhydroxy
methylcytosine (5ghmC) in double-stranded DNA.
Using PvuRts1I as the founding member, we define
a family of homologous proteins with similar DNA
modification-dependent recognition properties. At
the sequence level, these proteins share a few
uniquely conserved features. We show that these
enzymes introduce a double-stranded cleavage at
the 30-side away from the recognized modified
cytosine. The distances between the cleavage
sites and the modified cytosine are fixed within a
narrow range, with the majority being 11–13nt
away in the top strand and 9–10nt away in the
bottom strand. The recognition sites of these
enzymes generally require two cytosines on
opposite strand around the cleavage sites, i.e.
50-CN11–13#N9–10G-30/30-GN9–10#N11–13C-50, with at
least one cytosine being modified for efficient
cleavage. As one potential application for these
enzymes is to provide useful tools for selectively
mapping 5hmC sites, we have compared the
relative selectivity of a few PvuRts1I family
members towards different forms of modified cyto-
sines. Our results show that the inherently different
relative selectivity towards modified cytosines can
have practical implications for their application. By
using AbaSDFI, a PvuRts1I homolog with the highest
relative selectivity towards 5ghmC, to analyze rat
brain DNA, we show it is feasible to map genomic
5hmC sites close to base resolution. Our study
offers unique tools for determining more accurate
hydroxymethylomes in mammalian cells.
INTRODUCTION
Modiﬁcation-dependent restriction endonucleases are
widely present in bacterial genomes and are thought to
protect hosts from invading bacteriophages containing
modiﬁed DNA (1). Among many examples are the
T-even phages, in which only 5-hydroxymethylcytosines
(5hmC) are incorporated into the genome during replica-
tion and further modiﬁed to 5-glucosylhydrox
ymethylcytosine (5ghmC) by glucosyltransferases (1).
Although T4 wild-type DNA is resistant to most regular
restriction enzymes, there are types of modiﬁcation-
dependent restriction enzymes that are able to restrict
their infection in vivo, including PvuRts1I (2,3) among a
few others. For a long time, the detailed in vitro biochem-
ical properties of PvuRts1I remained obscure (4).
In mammalian genomes, it is commonly believed that
5-methylcytosine (5mC) is the major form of epigenetic
base modiﬁcation. Recently, the observation of 5hmC as
the enzymatic oxidative product of 5mC in mammalian
genomes (5,6) has added an extra layer of complexity to
the current understanding of epigenetic regulation and
spurred rising interest in determining its genomic locations
and metabolism. However, although the modiﬁed base
5hmC was discovered in bacteriophages >50 years ago
(7), there are few useful methods, either enzymatic or
chemical, to speciﬁcally recognize 5hmc residues and
pinpoint their locations in DNA, largely due to their
close structural similarity to 5mC. For example,
5mC-dependent endonucleases, such as the the MspJI
family (8) or McrBC (9), do not distinguish 5mC and
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HpaII, etc., in most cases are equally affected by 5mC
and 5hmC (4). The widely used bisulﬁte conversion
method cannot differentiate between 5mC and 5hmC
and reports both forms indistinguishably (10,11).
Recently, the availability of 5hmC-speciﬁc antibodies
has enabled a few enrichment-based methods [e.g.
hMeDIP (12)]. However, the format of the experiment,
based on afﬁnity pull-down, may limit the range of its
application, and the resolution of the data is still far
from base resolution.
Given mounting evidence for the importance of 5hmC
in mammalian epigenetics and the previous experimental
observations that PvuRts1I is able to speciﬁcally recognize
5hmC both in vivo and in vitro (3), we have set out to
investigate the in vitro biochemical properties of
PvuRts1I and its homologs identiﬁed in REBASE (4).
During the course of our study, Szwagierczak et al. (13)
reported that recombinant PvuRts1I selectively cleaves
5hmC-containing DNA substrates and that the
double-stranded cleavage sites are at N11–12/N9–10 on
the 30-side of the recognized 5hmC site. In addition, the




suggesting a likely in-cis dimerization cleavage process
(13). Still, there are a number of questions left un-
answered. For example, it is not clear whether PvuRts1I
is applicable for mapping genomic 5hmC sites along with
needing details concerning its practical use. In this regard,
a quantitative description of substrate selectivity on 5hmC
versus 5mC or unmodiﬁed cytosine is crucial, because in
most human tissue DNA, the level of 5hmC is usually on
the order of 0.01% of the total nucleotide (14). During our
investigation, we have observed that PvuRts1I is sensitive
to different puriﬁcation procedures, such that certain ions
used in the buffer may quickly inactivate most of the
enzyme in crude lysates (see ‘Results’ section). We have
thus optimized puriﬁcation conditions to obtain highly
active enzymes. Furthermore, we have observed that in
certain reaction conditions (e.g. reaction buffer or high
enzyme concentration), PvuRts1I starts to digest 5mC
and 5hmC indiscriminately (Figure 3 in Results). This
raises the concern of a possibly elevated false discovery
rate if it is used improperly, which must be carefully moni-
tored during its application.
In this article, we systematically characterized the en-
zymatic properties of several members in the PvuRts1I
family. In particular, we focus on comparing their sub-
strate selectivity on different forms of cytosine modiﬁca-
tions and evaluating their suitability in mapping genomic
5hmC sites. As one of the conclusions, we show that by
using AbaSDFI, a homolog of PvuRts1I with much
higher substrate selectivity, it is possible to map genomic
5hmC sites close to base resolution.
METHODS AND MATERIALS
Cloning, expression and puriﬁcation
Genes in the PvuRts1I family, including PvuRts1I, PpeHI
and AbaSDFI (Supplementary Table S1), were
synthesized using the optimized Escherichia coli codon
set from Integrated DNA Technologies Inc. They were
then sub-cloned into pTXB1, and overexpressed in E.
coli strain T7 Express (NEB #C2566). Cells were grown
at 30 C in LB medium with ampicillin to late log phase
and induced by IPTG at 16 C overnight. Cells were har-
vested by centrifugation and re-suspended in 0.5M
KOAc, 10mM Tris–OAc (pH 8.0) (column buffer).
After sonication and centrifugation, the clear supernatant
was loaded onto a chitin column (NEB #S6651), which
was equilibrated with the column buffer containing
0.1% Triton-X100. The column was washed with 50
column volumes of the column buffer. For intein
cleavage, the column was ﬂushed with the column buffer
containing 30mM DTT and incubated at 4 C overnight.
Fractions containing the puriﬁed protein were eluted from
the column using the column buffer.
Activities of enzymes were assayed on either T4 gt DNA
or T4 wt DNA, depending on the preference of each
enzyme. One unit of the enzyme is deﬁned as
the amount to digest 1mg of substrate DNA (T4 gt or
T4 wt) to completion in NEB buffer 4 at 23 C within
20min.
Salt sensitivity of PvuRts1I enzymes in crude lysate
To test the enzyme sensitivity to different salts in crude
lysates, 1.5ml PvuRts1I-expressing E. coli cells from over-
night culture were spun down and supernatant was
removed, then 1.5-ml 1-M Tris–acetate (pH 8.0) and
150ml of a 1-M solution of each different salt, all
buffered to pH 8.0 by its own ion type, were added.
Cells were then sonicated, spun again and left at 23 C
for 6h. The supernatant was then diluted in 10-, 100- or
1000-fold by diluent (250mM KOAc, 10mM Tris–acetate,
pH 8.0 and 200mg/ml BSA). Of diluted supernatant, 3ml
was tested for activity by incubating with 125ng T4 gt
DNA at 23 C for 20min in NEB buffer 4. The reactions
were stopped by adding 6  loading dye and visualized on
a 1% agarose gel (Figure 3).
Preparation of DNA substrates
To prepare the DNA substrates used in Figures 2C and
Figure 3, DNA fragments were PCR-ampliﬁed from the
T4 gt genomic or pUC19 DNA by using dATP/dGTP/
dTTP mixed with dhmCTP (Bioline #BIO-39046),
dmCTP (NEB #N0356S) or dCTP, respectively. PCRs
were carried out using Phusion polymerase (NEB
#M0530). The DNA fragment containing 5ghmC was
obtained by further modiﬁcation of 5hmC DNA
fragment by the T4 b-glucosyltransferase (NEB
#M0357). All PCR primers are listed in the
Supplementary Table S2.
The synthetic oligonucleotides used in Figure 4 were
made from PCR by using primers hmCG_ACGT_F and
hmCG_ACGT_R on the hmCG_ACGT_template in
the presence of dhmCTP /dATP/dGTP/dTTP
(Supplementary Table S3). The oligonucleotide sequence
is designed so that there is only one CG site (underlined in
Supplementary Table S3), which contains the 5hmC in the
top strand. Before PCR, each primer is individually
Nucleic Acids Research, 2011,Vol.39, No. 21 9295labeled by using g-
33P-ATP (Perkin-Elmer) and T4 poly-
nucleotide kinase (NEB #M0201), followed by puriﬁca-
tion using G-25 columns (GE Healthcare) to make the
50-end labeled substrates. PCR products were puriﬁed
from the QIAGEN Nucleotide Removal kit. To make
the 30-end labeled substrate, puriﬁed unlabeled PCR
product was incubated with Taq polymerase (NEB
#M0273) and a-
33P-dATP (Perkin-Elmer). This way
both of its 30-ends were labeled. As the ﬁnal step, all
labeled DNA fragments were further modiﬁed by T4
b-glucosyltransferase.
The synthetic oligonucleotides containing 5hmC used in
Figure 5 were synthesized in-house (Supplementary Table
S4). Each oligo was resuspended in H2Ot o2 0mM. Equal
volumes of top strand and bottom strand were then
mixed. The ﬁnal concentration of double-stranded sub-
strate is at 10mM. To be used as AbaSDFI substrate,
each double-stranded oligo was glucosylated using T4
b-glucosyltransferase. In Table 4, 5hmC_21C_top pairs
with 5hmC_215hmC_bottom as substrate used in
Figure 5B. Similarly, 5hmC_21C_top pairs with
5hmC_21mC_bottom (Figure 5C); 5hmC_21C_top pairs
with 5hmC_21C_bottom (Figure 5D); 5hmC_nonC_top
pairs with 5hmC_nonC_bottom (Figure 5E); C_21C_top
pairs with 5hmC_21C_bottom (Figure 5F).
Relative selectivity of the PvuRts1I enzymes
In each digestion series, 125ng substrate DNA was
digested by PvuRts1I, PpeHI or AbaSDFI in a 2-fold
serial dilution in NEB buffer 4 with additional KOAc
(ﬁnal concentration 250mM) for 20min at 23 C.
Addition of KOAc was found to signiﬁcantly inhibit the
enzyme activity on 5hmC, 5mC and C, with less effect on
5ghmC. The ratio of the relative selectivity is determined
by the comparison of the extent of digestion on different
substrates.
Sequence dependence on T4 genomic DNA
Of T4 gt DNA, 0.9mg was digested by PvuRts1I and
puriﬁed using spin columns. Digested DNA was then
treated with T4 DNA polymerase (NEB #M0203) for
end-polishing. The DNA fragments were ligated to
dephosphorylated linear pUC19 (linearized by HincII).
Colonies were picked after transformation to NEB
Turbo competent cells (C2984) and the inserts were
sequenced.
Genomic mapping of 5hmC sites
A total of 2mg rat brain genomic DNA from mixed tissue
was glucosylated using the T4 b-glucosyltransferase at
37 C overnight. After heat inactivation at 65 C for
20min, the DNA was then precipitated using isopropanol
and re-suspended in 20ml water. The digestion was
completed in a total volume of 30ml, with 3ml NEB
buffer 4, 6ml KOAc (2M, pH=8), 20ml glucosylated
gDNA and 100 U of AbaSDFI, at room temperature
for 1h. The DNA was then precipitated using isopro-
panol and re-suspended in 20ml water. Ligation was
performed in a total volume of 10.5ml, with 1ml ligation
buffer, 8ml DNA, 0.5ml of double-stranded adaptor
(P1b_top_2N+P1b_bottom for the 2N library or,
P1b_top_3N+P1b_bottom for the 3N library, both at
10mM, see Supplementary Table S4 for sequences), and
1ml T4 ligase (NEB #M0202), at room temperature for
overnight. The ligated DNA was then resolved on a 1%
low-melting agarose gel (Lonza #50080) with a DNA size
marker. The gel piece containing DNA fragments within
the 1–3 kb size range was excised and digested using
b-agarase (NEB #M0392). Adaptor-speciﬁc PCR was
prepared by using primer P1XbaIcloningprimer
(Supplementary Table S4) and Phusion DNA polymerase.
After PCR, the DNA fragments were cloned into the PmeI
site in pNEB193 and individually sequenced in 96-well
format (2 plates for the 2N library and 3 plates for the
3N library). The cloned genomic fragments were identiﬁed
by trimming the adaptor sequence (but leaving the
randomized 2N or 3N nt) and aligned to the rat reference
genome (REFSEQ ID: NC_005109.2) using BLASTN
(15). The ends of each cloned genomic fragment signify
half of the enzymatic cleavage sites. The other half of each
cleavage site was inferred by extracting the adjacent 30-nt
sequences from the reference genome and joined to the
cloned sequence for analysis (Figure 6).
RESULTS
Using PvuRts1I protein sequence as the query, we
searched the NR and ENV_NR databases at NCBI
using BLAST (15) and identiﬁed a number of homologs;
collectively, we call them the PvuRts1I enzyme family.
Using both in vivo phage restriction assays against T4
phages and in vitro digestion assays on modiﬁed DNA,
we evaluated the activity of each homolog and
summarized our results in Supplementary Table S1.
In the following, we focus our discussion on three rep-
resentative members in the family: PvuRts1I from
Proteus vulgaris Rts1, PpeHI from Proteus penneri
ATCC 35198 and AbaSDFI from Acinetobacter
baumannii SDF. All enzyme entries can be found in
REBASE (4).
Conserved sequence features deﬁne the PvuRts1I family
For a long time, PvuRts1I was placed into the ‘weirdo’
class of restriction endonucleases in REBASE (4), mainly
due to its unique biological properties and lack of detailed
experimental characterization. With our recent screening
efforts, we have identiﬁed a number of active PvuRts1I
homologs from complete bacterial genome sequences as
well as environmental sequences (Supplementary Table
S1 and Figure 1). These genes are signiﬁcantly similar to
each other at the sequence level, yet no previously known
conserved domains can be identiﬁed in the family.
Examination of the multiple sequence alignment
(Supplementary Figure S2) of the PvuRts1I family
protein sequences does not reveal the hallmarks of the
usual catalytic motifs that are often observable in the re-
striction endonucleases, such as PD...(D/E)XK or HNH
motifs, etc. (16). Figure 1A shows a schematic sequence
conservation proﬁle at the amino acid level abstracted
from the multiple sequence alignment (Supplementary
9296 Nucleic Acids Research, 2011,Vol.39, No. 21Figure S2) (17). The scale of the conservation is from 0 to
9, with 9 being most conserved. The absolutely conserved
residues and the predicted secondary structure elements
are shown on the top of the proﬁle in Figure 1A (18). It
appears that the N-terminal region of the PvuRts1I family
is more evolutionarily constrained, with more conserved
residues and more well-deﬁned structural elements than
the C-terminal region. In the absence of previously
known catalytic motifs, we attempted to identify potential
catalytically important residues based on conservation
and observed enzymatic properties. The activities of the
PvuRts1I enzymes are dependent on Mg
2+ in the reaction
buffer, suggesting the possible involvement of metal-ion
chelating residues. Figure 1B shows a multiple sequence
alignment encompassing a conserved cluster of negatively
charged residues in the N-terminal region (box B in
Figure 1A). It is likely that this region may be responsible
for metal ion binding and can act as the catalytic center.
Systematic mutagenesis experiments and structure deter-
mination are needed in the future to test the above
speculations.
Enzyme puriﬁcation and the in vitro
modiﬁcation-dependent activity
All genes were synthesized using optimized E. coli codons.
We ﬁrst fused a few genes with a 6 His-tag, either at the
N- or C-terminus, to facilitate quick puriﬁcation. To our
surprise, although a high level of cytosine modiﬁcation-
dependent activity was detected in the crude lysate of the
expression clones, a large portion of the activity was
quickly lost after puriﬁcation, even though the target
protein was successfully recovered and puriﬁed. It
appeared to us that the loss of activity may be due to
the speciﬁc chemicals used during puriﬁcation. We then
investigated the sensitivity of PvuRts1I enzymes in crude
lysates to different salt concentrations, as shown in
Figure 2A for PvuRts1I. Indeed, a high concentration of
imidazole salts, as routinely used for eluting the
His-tagged protein from chelating columns, leads to the
loss of the majority of the PvuRts1I activity in crude
lysates (Figure 2A, lanes d and e). High concentrations
of another anion, Cl
 , which is commonly used to
increase the ionic strength of the buffer, also seem to
Figure 1. Sequence features of the PvuRts1I family. (A) Sequence conservation proﬁles for the PvuRts1I family. Multiple Sequence Alignment and
secondary structure predictions were generated by PROMALS (18). Conservation scores (in 0–9 scale) were calculated at each aligned position by
AL2CO (17) and plotted. Absolutely conserved amino acids are shown on top of the conservation proﬁle. A detailed multiple sequence alignment in
box B is shown in (B). (B) A putative motif with conserved amino acids for binding metal ion and catalysis. The absolutely conserved amino acids
are indicated by stars.
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versible, since dilution or buffer change cannot restore the
lost enzymatic activities. Since the presence of high con-
centrations of NaCl or KCl can adversely affect PvuRts1I
enzyme in crude lysates, many common salt gradient
elution puriﬁcation schemes cannot be used as the ﬁrst
step. In Supplementary Figure S1, we show the salt sensi-
tivity of the two other enzymes, PpeHI and AbaSDFI. It
appears that the sensitivity proﬁle of each enzyme to a
speciﬁc salt also varies.
To ﬁnd a mild and universal puriﬁcation method, we
expressed the recombinant protein fused with a cleavable
intein and a chitin-binding domain (CBD) (19). First, the
fusion protein was bound to the chitin column under mild
conditions; then, the CBD tag of the fusion protein was
cleaved off by the embedded intein in the presence of
dithiothreitol (DTT) (19). Using this strategy, we
obtained each wild-type enzyme in highly active form
and close to homogeneity on an SDS-PAGE gel
(Figure 2B). The activity of each enzyme was assayed on
wild-type T4 (containing 5ghmC, referred to as T4 wt
hereafter) or a mutant phage T4 gt (containing 5hmC,
referred to as T4 gt hereafter) genomic DNA (see
‘Materials and Methods’ section). Table 1 lists the basic
properties of each puriﬁed enzyme. These preparations
were then used in the following characterization
experiments.
Figure 2C demonstrates the modiﬁcation-dependent
activity of AbaSDFI on a set of DNA fragments
designed to test modiﬁcation selectivity when a choice is
offered. Each differently sized fragment carries one form
of cytosine at all C locations—5ghmC, 5hmC, 5mC or
unmodiﬁed C. Under such competitive digestion condi-
tions, it can be seen that AbaSDFI digests 5ghmC- and
5hmC-containing DNA, but prefers the former, and does
not act on either 5mC- or C-containing DNA (Figure 2C).
Figure 2. Puriﬁcation of PvuRts1I family enzymes and in vitro modiﬁcation-dependent activity of AbaSDFI. (A) Sensitivity of PvuRts1I to different
salts in the crude lysate. a, potassium acetate; b, sodium phosphate; c, potassium phosphate; d, imidazole chloride; e, imidazole citrate; f, sodium
citrate; g, ammonium citrate; h, ammonium sulfate; i, sodium chloride; j, potassium chloride; k, cesium chloride; l, calcium chloride; m, sodium
sulfate; n, potassium sulfate; o, sodium carbonate; p, sodium nitrate. (B) SDS–PAGE of puriﬁed AbaSDFI, PpeHI and PvuRts1I. Of each protein,
1mg was loaded onto the gel. (C) In vitro modiﬁcation-dependent activity of AbaSDFI. 4 PCR products with different forms of cytosine were used as
substrate for a 5-fold titration of AbaSDFI digestion.
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It is known that wild-type restriction endonucleases some-
times exhibit activity on non-canonical sites under certain
in vitro conditions, e.g. high enzyme concentrations or
extended incubation times, etc. (20). These so-called
‘star’ activities usually do not impair the ﬁtness of the
bacterial hosts from which these enzymes originate and
are thus not selected against by nature, as the in vivo con-
centration of the enzymes is relatively low. Similarly, re-
striction endonucleases known to recognize one particular
modiﬁcation may exhibit activity on other modiﬁcations,
as long as these modiﬁcations are not present in the hosts
or are not deleterious. A good example is ScoMcrA, which
recognizes both DNA phosphorothioation and methyla-
tion (21). To use PvuRts1I-like enzymes to map 5hmC
sites in the mammalian genome, it is important to know
their relative selectivity to different modiﬁed cytosines, as
C, 5mC and 5hmC all exist in the genome and 5hmC
constitutes only a tiny fraction of the cytosine pool (14).
Enzymes with low relative substrate selectivity can result
in a high false discovery rate.
To quantify the relative selectivity of the PvuRts1I
enzymes on different cytosine modiﬁcations, we adopted
an approach similar to that previously used for regular
restriction endonucleases (20). For example, as shown in
Figure 3A, with an increasing 2-fold titration of puriﬁed
PvuRts1I, the enzyme shows a different activity proﬁle on
each substrate DNA. PvuRts1I acts on 5hmC and 5ghmC
DNA almost equally. When the enzyme concentration
is relatively high, PvuRts1I starts to digest DNA contain-
ing only 5mC and C as well. From a practical stand-
point of mapping 5hmC sites, this is undesired.
We deﬁne quantitatively the relative selectivity of each
enzyme as the ratio of speciﬁc activity on different
forms of modiﬁed cytosines. For example, the relative
selectivity for PvuRts1I is 5hmC:5ghmC:5mC:C=
2000:2000:8:1 (Figure 3A). Similarly, the relative select-
ivity for PpeHI is 5hmC:5ghmC:5mC:C=128:256:2:1
(Figure 3B); the relative selectivity for AbaSDFI is
5hmC:5ghmC:5mC:C=500:8000:1:ND (ND: none
detected) (Figure 3C). Figure 3D shows the comparison
of the three enzymes’ relative selectivity normalized based
on the activity towards 5mC. From the comparison, we
conclude that among the active PvuRts1I-like enzymes we
characterized, AbaSDFI has the best discriminative power
on 5ghmC over 5mC and C. In addition, only AbaSDFI
does not have detectable activity towards unmodiﬁed
cytosine (Figure 3D). These properties were used in our
5hmC site mapping experiment (see below). Here, we
consider 5ghmC equally important as 5hmC because
although 5ghmC is not known to be present in the
mammalian genome, in vitro 5hmC can be converted
to 5ghmC essentially completely using the T4
b-glucosyltransferase (22).
Cleavage properties of PvuRts1I enzymes
To investigate the cleavage positions of PvuRts1I enzymes
near the modiﬁed sites, we individually labeled oligo-
nucleotide substrates at either the 50- or the 30-ends
(Figure 4A). In the example shown in Figure 4B, the
enzyme used was AbaSDFI and the recognition site is a
hemi-5ghmC site in the top strand. In Figure 4B, left
panel, the top-strand-labeled substrate (lane 2) and the
bottom-strand-labeled substrate (lane 1) were separately
digested by AbaSDFI. The digested products were
resolved on a denaturing polyacrylamide gel to single
base resolution for small fragments and compared with
synthetic size markers for the bottom strand cleavage
site (Figure 4B, left panel). It can be seen that AbaSDFI
cleaves both the top strand and the bottom strand on the
30-side of the recognition site, producing a large-labeled
fragment from the top-strand-labeled substrate (lane 2)
and a short-labeled fragment from the bottom-
strand-labeled substrate (lane 1). The bottom strand
cleavage products are of a size that allows discrimination
at single-base resolution. The distance from the bottom
strand cleavage site to the modiﬁed cytosine is predomin-
ately 10nt for this particular substrate, with minor
cleavage plus or minus 1nt.
To precisely map the top strand cleavage site,
a-
33P-dATP was incorporated into the 30-ends of both
strands by the non-templated polymerization activity of
Taq polymerase. The AbaSDFI-digested products were
resolved by PAGE (Figure 4B, right panel) and
compared with synthetic size markers (Figure 4A). From
lane 3 in Figure 4B right panel, the top-strand cleavage
site can be deduced to be 12 or 13nt away from the 30-side
of the modiﬁed cytosine for this particular substrate.
Overall, our results suggest that AbaSDFI generates a
double-stranded cleavage on the 30-side and away from the
modiﬁed cytosine. The substrate tested in Figure 4 is
hemi-modiﬁed. We have additionally tested fully
modiﬁed sites and observed activity. For a fully
modiﬁed site, AbaSDFI cleaves on both sides of the site,
essentially carving a small fragment from the DNA, like
enzymes in the MspJI family (8). The difference is that the
cleavage distance from the recognition site for MspJI
(N12/N16) is longer than that of PvuRts1I. Thus,
whereas MspJI can produce 32-mer fragments from the
fully modiﬁed sites, the length of such small fragments for
PvuRts1I is  24bp, which may provide only limited
Table 1. Puriﬁed members in the PvuRts1I family






PvuRts1I 11 5300000 (T4gt) 480000
PpeHI 41 2600000 (T4gt) 65000
AbaSDFI 17 1300000 (T4wt) 76000
Nucleic Acids Research, 2011,Vol.39, No. 21 9299resolution power in the human genome if sequenced. Since
the amount of 5hmC is usually very low, we have not
visually observed the appearance of the 24-mer band
from the digestion of different genomic DNAs using
PvuRts1I-family enzymes. Another intriguing observation
according to our experiment is that AbaSDFI generates a
mixture of fragments with either 2- or 3-base 30-overhang,
which provides the basis for our later genomic mapping
experiment (see below).
Sequence dependency of the PvuRts1I enzymes
To determine whether PvuRts1I enzymes require other
sequence elements in addition to modiﬁed cytosines, we
initially cloned and sequenced the digested T4 wt or T4 gt
genomic DNA fragments. The T4 wt or gt genomic DNA
provides a complex, fully modiﬁed substrate, thus
allowing identiﬁcation of preference for sequence
context. Brieﬂy, T4 gt DNA was digested by PvuRts1I
to completion. The digested DNA fragments were
blunt-ended by DNA polymerases and cloned into
pUC19 for sequencing (see ‘Materials and Methods’
section for details). After mapping the inserts to the T4
genome, the sequences encompassing the ends of the
inserts, which signify the cleavage sites of PvuRts1I, are
subject to further analysis for compositional bias. The
identiﬁed consensus recognition sites are shown in
Supplementary Figure S3. Two 5hmCs on opposite
strands are signiﬁcantly enriched on either side of the
cleavage site, with distance to the cleavage site either
12nt (top strand cut) or 9–10nt (bottom strand cut)
(Supplementary Figure S3). The distances between the
two 5hmCs are either 21nt (47% of all cases) or 22nt
(45% of all cases), which reﬂects the variable cleavage
positions of the enzyme. Importantly, there is little com-
positional bias in the adjacent positions of the two 5hmC
(Supplementary Figure S3), suggesting the possibility that
Figure 3. Relative selectivity of PvuRts1I, PpeHI and AbaSDFI on unmodiﬁed cytosine (C), 5mC, 5hmC and 5ghmC (see ‘Materials and Methods’
section for description of methods). In each gel, the amount of enzyme is titrated from left (high) to right (low). All DNA substrates were made by
PCR. (A) PvuRts1I, the approximate relative selectivity is 5hmC:5ghmC:5mC:C=2000:2000:8:1; (B) PpeHI, the approximate relative selectivity is
5hmC:5ghmC:5mC:C=128:256:2:1; (C) AbaSDFI, the approximate relative selectivity is 5hmC:5ghmC:5mC:C=500:8000:1:ND (none detected).
(D) Comparison of the relative selectivity on 5ghmC, 5hmC, 5mC and C among PvuRts1I, PpeHI and AbaSDFI. The relative selectivity is plotted in
log scale and normalized based on the 5mC activity.
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ﬁndings in this experiment are consistent with the study
published from Szwagierczak et al. (13).
The symmetrical conﬁguration of the recognition sites
suggests a possible cleavage process in which two individ-
ual monomers bind, one to each modiﬁed site, then
interact through dimerization leading to double-stranded
cleavage. On the other hand, it is important to realize that
all cytosines in the T4 wt or T4 gt DNA are in the form of
5ghmC or 5hmC. To provide further experimental support
for the dimerization hypothesis, we tested whether there is
a dependence on the modiﬁcation status of the suitably
placed cytosines on opposite strands. Figure 5 compares
the activity of AbaSDFI on synthetic oligonucleotides
containing designed sites with one constant 5ghmC and
another base, either as 5ghmC (Figure 5B), 5mC
(Figure 5C), unmodiﬁed C (Figure 5D) or no cytosine
properly placed in the opposite strand (Figure 5E). As a
control, Figure 5F shows that AbaSDFI does not act on
non-modiﬁed DNA substrate. By comparing the cleavage
efﬁciency in Figure 5, it can be concluded that the cleavage
efﬁciency decreases  25-fold when one of the two 5ghmCs
in the recognition site changes to 5mC or unmodiﬁed C.
However, the cleavage efﬁciency drops dramatically when
there is no cytosine within the suitable distance range in
the opposite strand (Figure 5A and E). Supplementary
Figure S4 shows the activity of PvuRts1I on the same
set of oligonucleotide substrates (without glucosylation).
Similar to AbaSDFI, PvuRts1I prefers sites with two
properly placed 5hmC (Supplementary Figure S4B).
Sites with one 5mC or one C are digested with a lower
efﬁciency (Supplementary Figure S4CD). The efﬁciency
further drops on sites with only one 5hmC
(Supplementary Figure S4E). Consistent with the results
in Figure 3, PvuRts1I even digests unmodiﬁed DNA sub-
strate in high concentration (Supplementary Figure S4F).
These results further support the high substrate selectivity
of AbaSDFI.
Overall, it appears that the PvuRts1I-family of enzymes
recognizes two cytosines on opposite strands, which are
separated by 21 or 22nt and at least one cytosine needs to
be suitably modiﬁed as 5hmC or 5ghmC.
Mapping 5hmC sites in mammalian genomic DNA using
AbaSDFI
The property of introducing a double-stranded cleavage at
a narrowly speciﬁed distance from 5hmC sites by the
PvuRts1I family enzymes suggests a potential application
for mapping genomic 5hmC sites. As a proof-of-principle
experiment, we chose the enzyme AbaSDFI, which has the
highest relative selectivity on 5ghmC versus 5mC or C.
Brieﬂy, we ﬁrst glucosylated rat brain genomic DNA,
using recombinant T4 b-glucosyltransferase (see
‘Materials and Methods’ section for details). AbaSDFI
was then used to digest the glucosylated genomic DNA.
The digested DNA was then ligated with a
double-stranded adaptor with either a 2- or 3-base
randomized 30-overhang, which are referred as the 2N
or the 3N libraries hereafter. The ligated DNA was
size-selected from 1 to 3kb on an agarose gel and
PCR-ampliﬁed with an adaptor-speciﬁc primer. The
ampliﬁed DNA was cloned into pUC19 for sequencing
the inserts. The sequenced inserts were then aligned to
the rat reference genome to identify the cleavage sites at
both ends.
Figure 6 summarizes the analysis of the sequence frag-
ments around the 122 identiﬁed cleavage sites in the 2N
library. One of the advantages of using the 2N adaptor is
Figure 4. Cleavage position of AbaSDFI near a hemi-5ghmC site.
(A) The structure of the oligonucleotide used. The modiﬁed cytosine
and the positions of the synthetic markers are indicated. (B) Digested
labeled oligonucleotides resolved in a 20% polyacrylamide 7M urea
denaturing gel. Left panel: lane 1, bottom strand 50-labeled; lane 2,
top strand 50-labeled; M1, synthetic markers indicated on the bottom
strand in (A). Right panel: lane 3, 30-labeled on both strands; M2,
synthetic markers indicated on the top strand in (A). Schematic
drawings of the digested products are shown on the side of the gels
corresponding to digested bands.
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DNA fragments to allow precise determination of the
cleavage sites in both strands from the sequencing data.
By considering the variable cleavage distance of the
enzyme, i.e. either 12/10 (denoted as C12/10, C is the
cytosine being recognized) or 11/9 (denoted as C11/9) for
the 2N library, the sequences around the cleavage sites can
be grouped based on a few different conﬁgurations
(Figure 6AB), for example, sequences with two symmet-
rical C12/10 cleavages, sequences with two symmetrical C11/
9 cleavages, or, sequences with 1 C12/10 a n d1C 11/9 cleav-
ages, etc.(Figure 6B). Figure 6B shows the comparison on
the frequency of occurrences of these sites between the
cloned library and those expected by chance. For
example,  20% of the cleavage sites have two symmetrical
C12/10 (category 2) and  20% have two symmetrical C11/9
(category 1), which are signiﬁcantly higher than 3.5%
expected by chance (Figure 6B). The same signiﬁcant
overrepresentation is seen for sites with 1 C12/10 and 1
C11/9 (category 3 in Figure 6B). While these conﬁgurations
are signiﬁcantly overrepresented in the cloned library, sites
with C in only one side of the cleavage sites (category 5 in
Figure 6B), or, sites with no suitable C in the vicinity of
the cleavage sites (category 6 in Figure 6B) only constitute
11% and 3.3% of the cloned library respectively, much
lower than the 49% and 32% expected by chance. Thus,
it appears that sites that are not recognized by AbaSDFI
are signiﬁcantly underrepresented in the cloned library.
There are  20% of the sequences which contain ‘C12/
10C11/9’ as a half site and a C12/10 or C11/9 as the other
half site (category 4 in Figure 6B). For these, we could not
determine which C in the ‘CC’ is recognized by the
enzyme. Nevertheless, they are signiﬁcantly
overrepresented as well and may be 5hmC-containing
sites. Overall, a high percentage (86%) of all the
cleavage sites appears to be true cleavage sites catalyzed
by the enzyme.
Figure 5. Activity of AbaSDFI on synthetic oligonucleotides with different modiﬁed recognition sites. (A) Expected digested fragments from
AbaSDFI digestion. Sequences of the oligonucleotide can be found in Supplementary Table S4; (B) Activity of AbaSDFI on the synthetic oligo-
nucleotide with two 5ghmC, separated by 21nt; 5pmol of DNA substrate was digested using a titration of AbaSDFI and resolved on a 20%
polyacrylamide PAGE. The gel was stained with SYBR Gold. (C) Activity of AbaSDFI on the synthetic oligonucleotide with one 5ghmC and one
5mC; (D) activity of AbaSDFI on the synthetic oligonucleotide with one 5ghmC and one C; (E) activity of AbaSDFI on the synthetic oligonucleotide
with only one 5ghmC and no cytosine in the region 20–25nt away (Supplementary Table S4); (F) activity of AbaSDFI on the synthetic oligo-
nucleotide with two unmodiﬁed C [compare with substrate in (D)].
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the sites in categories 1 (symmetrical C11/9), 2 (symmetrical
C12/10) and 3 (1 C12/10 1C 11/9) in Figure 6B (23).
Supplementary Figures S6 and S7 list the aligned se-
quences in categories 1 and 2. It is important to realize
that due to the symmetrical nature of the AbaSDFI rec-
ognition sites, the motifs presented in Figure 6C do not
distinguish which of the two cytosines around the cleavage
sites is the real 5ghmC site. Based on the results in
Figure 5, it is possible that both cytosines are 5hmC, or,
Figure 6. Analysis of the mapped cleavage sites of AbaSDFI in the 2N library from rat brain genomic DNA. (A) Schematic drawing of the
recognition sites. ‘N’ indicates the positions analyzed; (B) comparison of site distribution in sequenced library and expected by chance. A total
of the 122 mapped cleavage sites in the 2N library were analyzed. Each category (1–6) represents a particular site conﬁguration. Blue bars show the
percentages expected by chance. Red bars show the percentage in the analyzed data set. 1: symmetrical 11/9 cuts, denoted as C12/10C11/9/C11/9C12/10,
which means both left and right N11/9 position is C, both left and right N12/10 position is NOT C (underlined). The expected percentage is calculated
as 0.75*0.25*0.25*0.75=3.5%; 2: symmetrical 12/10 cuts, C12/10C11/9/C11/9C12/10; 3: one side 11/9 cut, the other side 12/10 cut, C12/10C11/9/C11/9C12/10
or C12/10C11/9/C11/9C12/10; 4: sites with C12/10C11/9 as one side, the other side is either C12/10 or C11/9; 5: site with C12/10 or C11/9 as one side, the other
side does not have C; 6: both sides do not have C. (C) Sequence logos in categories with two symmetrical C12/10 cuts, two symmetrical C11/9 cuts, and
1C 12/10 1C 11/9 cuts. The sequence logos are generated by Weblogo (23).
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Indeed, this may be reﬂected by the appearance of the
enriched CG dinucleotide encompassing the recognized
cytosines in Figure 6C. On the one hand, it is expected
since the 5hmCs most likely arise from the methylated
CpG sites from the action of the TET enzymes in the
brain DNA (5); on the other hand, the methylated CG
sites may also constitute half of the recognition sites for
AbaSDFI. Interestingly, the ﬂanking position on the
50-side of the recognized C shows an overrepresentation
of A or T in the symmetrical C11/9 cleavages, whereas it is
absent in the symmetrical C12/10 cleavages (Figure 6C).
This suggests that the cleavage distance may be affected
by the nucleotide ﬂanking the recognized cytosine.
Further experiments are needed to test this hypothesis.
In addition, Supplementary Figure S5 summarizes the
analysis of 188 sequenced cleavage sites in the 3N
library from which similar observations can be made.
DISCUSSION
In this article, we compared the in vitro biochemical
properties of a few members in the PvuRts1I family.
The ﬁrst example of this family, PvuRts1I, was known
to restrict T-even bacteriophages with 5hmC or 5ghmC
in their genomic DNA (3). Using a relatively mild puriﬁ-
cation procedure, we were able to obtain pure enzymes in
highly active form; all exhibit DNA modiﬁcation-
dependent endonuclease activity with similar cleavage
properties. In addition, our results suggest that these
enzymes differ from each other in their relative selectivity
toward various forms of modiﬁed cytosine. The relative
selectivity provides a quantitative index of their ‘ﬁdelity’
towards each desired forms of modiﬁed cytosine. From
the application perspective, this is important due to the
extremely low abundance of 5hmC compared with the
5mC and C in the genome. As a result, we ﬁnd that
AbaSDFI, a homolog of PvuRts1I, has the highest
(8000:1) relative selectivity between 5ghmC and 5mC.
Furthermore, it does not have any detectable activity on
unmodiﬁed C. These properties allow reliable mapping of
genomic 5hmC sites in large mammalian genomes. This
high selectivity may also reﬂect the enzyme’s inherent
ability to distinguish the major structural difference
between 5ghmC and 5mC.
The PvuRts1I family differs from many other
well-studied restriction endonucleases in several aspects.
First, they display no identiﬁable previously known
motifs for metal-ion chelation or catalysis, suggesting a
novel enzymatic DNA cleavage chemistry. Multiple
sequence alignment reveals that the N-terminal region is
more conserved than the C-terminal region both in amino
acid sequence and in the secondary structure elements
(Figure 1A). There are strings of conserved positions in
both the N-terminal and the C-terminal regions
(Figure 1A). We surmise that a cluster of conserved
acidic residues in the N-terminal region may be respon-
sible for chelating Mg
2+ and could form part of the active
center (Figure 1B). Furthermore, it is tempting to assume
the nearby conserved histidines may act as the general
base in the cleavage process (16). If true, this implies a
domain organization with the N-terminus responsible
for cleavage activity and the C-terminus responsible for
binding. This is different from the domain organization of
other type IIS restriction endonucleases such as FokI (24)
or MspJI (8), which have an N-terminal domain for
binding and a C-terminal domain for cleavage, but is
similar to that of MmeI (25). Site-directed mutagenesis
and structure determination will be needed for further elu-
cidation. Second, the requirement of two cytosines within
a deﬁned distance range on separate DNA strands
suggests a likely dimerization step in the cleavage
process. Intriguingly, our results suggest that as long as
one binding site contains the recognized modiﬁed
cytosine, e.g. 5hmC or 5ghmC, the other site can be
5mC, or even unmodiﬁed cytosine, with moderate
decrease of the cleavage efﬁciency (Figure 5). It is
possible that PvuRts1I-like enzymes recognize not only
the 5-modiﬁcation on the cytosine, but also other struc-
tural elements of cytosine; this may explain why two cyto-
sines are required for cleavage. Further biochemical
studies are needed to clarify the role of the second
cytosine.
Theoretically, the coverage of 5hmC sites using the
PvuRts1I-like enzymes could be quite high, due to its
ﬂexible requirement for the binding sites. Based on our
data, for each 5hmC site, as long as there is another
cytosine, modiﬁed or not, at its 30-side in the opposite
strand and 20–22nt away, it should elicit enzymatic
cleavage. This translates to a theoretical coverage of
 58% (1 0.75*0.75*0.75), assuming there is no severe
bias of base composition in the genome. In our
proof-of-principle experiment in Figure 6, all the
mapped sites contain at least one 5hmC. Although there
is still ambiguity in the results as to which cytosine is the
real 5hmC, this provides a much higher resolution than
the hMeDIP-like approaches and may offer better insights
into the existence of 5hmC in the genome. Future experi-
ments will see the application of these enzymes in the
genomic mapping of different cell types using the latest
high-throughput sequencing technologies.
The in vitro biochemical properties of the PvuRts1I
enzymes dictate the experimental approaches to mapping
genomic 5hmC sites along with the computational inter-
pretation of the sequencing data. Because these enzymes
can generate a mixture of ends from a single recognition
site, we used double-stranded DNA adaptors with
randomized 2- or 3-base 30-overhangs to separate the
population. This provides the advantage of precisely
locating the cleavage sites in both DNA strands in the
sequencing data, which in turn reduces the uncertainty
in searching for the nearby recognition sites. Given
the variable cleavage distance property of the
PvuRts1I enzymes, this may be a crucial step in library
construction.
In summary, the PvuRts1I family of enzymes deﬁnes a
unique group of DNA modiﬁcation-dependent restriction
endonucleases. Having them and combined with the
high-throughput sequencing platforms, it should be
possible to improve the resolution of the current
hydroxymethylomes in mammalian cells.
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